China Life Valuation
| 601628 Stock | 37.85 0.05 0.13% |
At this time, the firm appears to be fairly valued. China Life Insurance shows a prevailing Real Value of USD39.03 per share. The current price of the firm is USD37.85. Our model approximates the value of China Life Insurance from analyzing the firm fundamentals such as Profit Margin of 0.11 %, current valuation of 871.57 B, and Return On Equity of 0.17 as well as examining its technical indicators and probability of bankruptcy.
Price Book 1.8853 | Enterprise Value 871.6 B | Price Sales 1.1014 | Forward PE 19.1939 | Trailing PE 12.1419 |
Fairly Valued
Today
Please note that China Life's price fluctuation is very steady at this time. Calculation of the real value of China Life Insurance is based on 3 months time horizon. Increasing China Life's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since China Life is currently traded on the exchange, buyers and sellers on that exchange determine the market value of China Stock. However, China Life's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 37.85 | Real 39.03 | Hype 37.92 | Naive 39.24 |
The real value of China Stock, also known as its intrinsic value, is the underlying worth of China Life Insurance Company, which is reflected in its stock price. It is based on China Life's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of China Life's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of China Life Insurance helps investors to forecast how China stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of China Life more accurately as focusing exclusively on China Life's fundamentals will not take into account other important factors: China Life Cash |
|
China Life Total Value Analysis
China Life Insurance is presently forecasted to have takeover price of 871.57 B with market capitalization of 895.34 B, debt of 5.42 T, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the China Life fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
871.57 B | 895.34 B | 5.42 T |
China Life Investor Information
About 94.0% of the company shares are owned by institutions such as pension funds. The company has Price-to-Book (P/B) ratio of 1.89. In the past many companies with similar price-to-book ratios have beat the market. China Life Insurance has Price/Earnings To Growth (PEG) ratio of 0.98. The entity last dividend was issued on the 13th of November 2024. The firm had 2.6666:1 split on the 29th of December 2006. Based on the measurements of operating efficiency obtained from China Life's historical financial statements, China Life Insurance is not in a good financial situation at the present time. It has a very high chance of going through financial crunch in April.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | 38.7 B | 64.4 B |
|
|
China Life Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of China suggests not a very effective usage of assets in March.China Life Ownership Allocation
China Life holds a total of 20.82 Billion outstanding shares. The majority of China Life Insurance outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in China Life Insurance to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in China Life. Please pay attention to any change in the institutional holdings of China Life Insurance as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.China Life Profitability Analysis
The company reported the revenue of 829.26 B. Net Income was 21.11 B with profit before overhead, payroll, taxes, and interest of 143.69 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates China Life's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in China Life and how it compares across the competition.
About China Life Valuation
The stock valuation mechanism determines China Life's current worth on a weekly basis. Our valuation model uses a comparative analysis of China Life. We calculate exposure to China Life's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of China Life's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 123.1 B | 82.9 B |
China Life Quarterly Retained Earnings |
|
Complementary Tools for China Stock analysis
When running China Life's price analysis, check to measure China Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China Life is operating at the current time. Most of China Life's value examination focuses on studying past and present price action to predict the probability of China Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China Life's price. Additionally, you may evaluate how the addition of China Life to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |